are glp-1 receptor agonists banned by wada 2025 Critics debating whether the medications should be in sports for potentially being performance-enhancing drugs Ozempic On WADA's Monitoring List
Description
Koskinas KC, Van Craenenbroeck EM, Antoniades C, et al
16 Because the therapeutic potential of natural GLP-1 is limited due to its rapid degradation by the enzyme dipeptidyl peptidase 4 (DPP-4), GLP-1 analogs have been developed that are DPP-4 resistant
Figure 12: Photograph Professor Vincent Marks (1930-2023), credit: Seaton)
However, each case is different and all aspects and context of the case need to be taken into account during the results management process
doi: 10.1016/j.jacbts.2018.09.004 126 RizzoMNikolicDPattiAMManninaCMontaltoGMcAdamsBSet al
